Cargando…
Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients
BACKGROUND: Sensorineural hearing loss (SNHL) is one of the major long term side effects from radiation therapy (RT) in nasopharyngeal cancer (NPC) patients. This study aims to review the incidences of SNHL when treating with different radiation techniques. The additional objective is to determine t...
Autores principales: | Petsuksiri, Janjira, Sermsree, Achariyaporn, Thephamongkhol, Kullathorn, Keskool, Phawin, Thongyai, Kanthong, Chansilpa, Yaowalak, Pattaranutaporn, Pittayapoom |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048471/ https://www.ncbi.nlm.nih.gov/pubmed/21333025 http://dx.doi.org/10.1186/1748-717X-6-19 |
Ejemplares similares
-
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2018) -
Concurrent chemoradiotherapy for T3–4 and N0–1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia
por: Ohno, Tatsuya, et al.
Publicado: (2016) -
Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2–3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in Asia
por: Ohno, Tatsuya, et al.
Publicado: (2013) -
Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2021) -
Post-Operative Concurrent Chemoradiation for Patients with Non-Squamous Cell Carcinoma of Head and Neck: A Retrospective Cohort of the Uncommon Cancers
por: Thamlikitkul, Lucksamon, et al.
Publicado: (2019)